BioCardia, Inc. Schedule 13G Filing by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC

This Schedule 13G filing reports the beneficial ownership of BioCardia, Inc. common stock by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. As of September 24, 2025, each of the reporting persons may be deemed to have beneficial ownership of 557,179 shares of common stock, representing approximately 4.99% of the outstanding shares. The filing is made pursuant to Rule 13d-1(c) and includes a joint filing agreement. The reporting persons certify that the securities were not acquired for the purpose of influencing the control of the issuer.